NEUROASPIS® Plp10 The Novel Nutraceutical Intervention as an Adjuvant Treatment for Multiple Sclerosis – “Specific PUFAs and antioxidant vitamins fulfil the criterion of biological plausibility and have the potential to diminish the severity and activity of MS symptoms, potentially even promoting recovery (remyelination)” https://www.ecronicon.com/eco16/pdf/ECNE-01-ECO-02.pdf
APOE ε4 and the associations of seafood and long-chain omega-3 fatty acids with cognitive decline
NEUROASPIS® plp10 was presented at the 7th International Conference on Drug Discovery and Therapy, Dubai, February 2016. The session on NEUROASPIS® plp10 was presented by Prof. Dr I. Patrikios.
NEUROASPIS® plp10 was presented at the 3rd Panhellenic Congress of the Hellenic Academy of NeuroImmunology on Multiple Sclerosis, Athens, 2015
The 3rd International Polythematic Scientific Bio-Medical Congress titled “Bio-Medical Scientific Cyprus” took place on Saturday, November 14th 2015, at the European University Cultural Center.
NEUROASPIS® plp10 was presented at the 31st Congress of the European Committee for Treatment and Research in Multiple Sclerosis
A novel oral nutraceutical formula of omega-3 and omega-6 fatty acids with vitamins (PLP10) in relapsing remitting multiple sclerosis: a randomised, double-blind, placebo-controlled proof-of-concept clinical trial
Specific Omega3, Omega-6 Polyunsaturated Fatty Acids and γ-Tocopherol in the Therapy of Relapsing Multiple Sclerosis: the Paradigm of the PLP10 Intervention Efficacy and Correlation to the Molecular Alteration of the Red blood Cells’ Membranes
Systems Medicine, Applying Systems Biology Approaches for Manipulation of Altered Biomechanisms towards Multiple Sclerosis Treatment by the Use of Specific Structured molecules and Antioxidant Vitamins: the PLP10 intervention Paradigm
Systems Medicine, Applying Systems Biology Approaches for Multiple Sclerosis Treatment by the Use of Specific Structured Μolecules and Antioxidant Vitamins: the PLP10 Novel Ιntervention Paradigm
